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Abstract
Long-chain saturated and monounsaturated fatty acids differ
in their propensity to induce b-cell death in vitro with
palmitate (C16:0) being cytotoxic, whereas palmitoleate
(C16:1n-7) is cytoprotective. We now show that this
cytoprotective capacity extends to a poorly metabolised
C16:1n-7 derivative, methyl-palmitoleate (0.25 mM palmi-
tate alone: 92G4% death after 18 h; palmitate plus 0.25 mM
methyl-palmitoleate: 12G2%; P!0.001). Palmitoleate and
its methylated derivative also acted as mitogens in cultured b-
cells (5-bromo-2-deoxyuridine incorporation – control:
0.15G0.01 units; 0.25 mM palmitoleate: 0.22G0.01 units;
P!0.05). It has been proposed that alterations in neutral lipid
synthesis (particularly triacylglycerol (TAG) formation) might
mediate the differential responses to saturated and unsaturated
fatty acids and we have examined this proposition. Palmitate
and palmitoleate both promoted b-cell phospholipid remo-
delling and increased TAG formation (control: 0.9G
0.1 nmol TAG/10
6 cells; 0.25 mM palmitate: 1.55G0.07;
0.25 mM palmitoleate: 1.4G0.05; palmitate plus palmitole-
ate: 2.3G0.1). By contrast, methyl-palmitoleate failed to
inﬂuence TAG levels (0.25 mM methyl-palmitoleate alone:
0.95G0.06 nmol TAG/10
6 cells; methyl-palmitoleate plus
palmitate: 1.5G0.05) or its fatty acid composition in b-cells
exposed to palmitate. The results suggest that monounsatu-
rated fatty acids can promote cell viability and mitogenesis by
a mechanism that does not require their metabolism and is
independent of alterations in TAG formation.
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Introduction
The prevalence of type 2 diabetes is rising rapidly in many
regions of the world, driven, in part, by changing lifestyles and
dietary habits. In particular, it appears to be associated with
increases in obesity, leading to alterations in the circulating lipid
proﬁle of affected individuals (Rhodes 2005, Kahn et al. 2006).
This is signiﬁcant since the disease is characterised by impaired
insulin secretion and loss of insulin sensitivity followed by a
progressivedeclineinb-cellmass,allofwhichmaybeinﬂuenced
by alterations in lipid availability (Shimabukuro et al. 1998b,
Ahren 2005, Marchetti et al. 2006, Newsholme et al. 2007).
Acuteexposureofb-cellstofreefattyacids(FFA)invitroleads
to enhanced rates of insulin secretion (Sako & Grill 1990,
Newsholmeetal.2007),whereasmoreprolongedtreatmentcan
be associated with toxicity (Lupi et al. 2002, El-Assaad et al.
2003, Haber etal. 2003, 2006, Rhodes 2005, Azevedo-Martins
etal.2006).However,thelatteroccursmoredramaticallyduring
exposuretolong-chainsaturatedFFA(e.g.palmitate(C16:0)or
stearate (C18:0)) than in response to either shorter chain
saturated (C14orless) orlonger chainunsaturated FFA (such as
palmitoleate (C16:1n-7) oroleate (C18:1n-9)). Indeed, there is
increasing evidence that when used within the physiological
range of free concentrations, the latter species are directly
cytoprotective to b-cells (Eitel et al. 2002, Maedler et al. 2003,
Welters etal.2004,2006)although,whenpresentinsufﬁciently
high free concentrations, all fatty acids are likely to exert
detrimental effects (Azevedo-Martins et al. 2006).
Since long-chain saturated and long-chain monounsaturated
FFA can exert differential effects on b-cell viability, this implies
thattheymustalsoelicitdifferentintracellular responsesinorder
to mediate these effects. Such differences have proved elusive to
deﬁne but changes in neutral lipid accumulation could be
involved since b-cells can store excess FFA in the form of
triacylglycerol (TAG; Briaud et al. 2001, Unger & Zhou 2001,
Unger & Orci 2002, Mofﬁtt et al. 2005). However, the
mechanistic consequences of this response have become the
source of considerable debate with some investigators,
proposing that diversion of FFA into intracellular TAG serves
a cytoprotective function (Cnop et al. 2001, Listenberger et al.
2003), while others (e.g. Briaud et al. 2001, Mofﬁtt et al. 2005)
have seen this as a potentially toxic response.
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pancreaticb-cellstoincubationwithextracellularFFAinvitroin
moredetail.WehaveemployedarangeofmodiﬁedFFAspecies,
both saturated and unsaturated, and have investigated whether
the propensity of these to regulate cell viability correlates with
their potential for intracellular metabolism to TAG.
Materials and Methods
Cell culture
The rat pancreatic b-cell line BRIN-BD11 was used in all
experiments. The cells were cultured in RPMI-1640 medium
(Invitrogen) containing 11 mM glucose supplemented with
10%fetalcalfserum(PAALaboratories,Yeovil,Somerset,UK),
2m M L-glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin (Invitrogen). The cells were grown in 75 cm
2
ﬂasks at 37 8C and 5% CO2.
Treatment of cells with fatty acids
Stock solutions of 50 mM palmitate (Sigma) or
2-bromopalmitate (Avocado research chemicals, Morecambe,
Lancs, UK) were prepared in 50% ethanol by heating to 70 8C.
Palmitoleate (MP Biomedicals, Cambridge, UK) and methyl-
palmitoleate (Sigma) were prepared by mixing with 90% ethanol
at room temperature to produce stock solutions of 90 mM. The
fatty acid preparations were then bound to 10% fatty acid-free
BSA (MP Biomedicals) by incubation for 1 h at 37 8C. The
mixture was added to RPMI-1640 medium (containing 11 mM
glucose) deprived of fetal calf serum. The ﬁnal concentrations
present in the cell environment were 1% for BSA and 0.5% for
ethanol. Cells were seeded into six-well plates at densities of 1!
10
5 cells/well and incubated for 2 4hi nc o m p l e t eR P M I - 1 6 4 0
medium. The medium was then removed and replaced with
relevant fatty acid/BSA complexes (in RPMI-1640 devoid of
foetal calf serum) for a further 18 h. Controls received BSA and
vehicle only.
Vital dye staining for estimation of viability
Following incubation, ﬂoating and attached cells were
collected, centrifuged at 200 g for 5 min and resuspended in
250 ml complete RPMI-1640 plus 250 ml Trypan blue (0.4%
in PBS). Viable and dead cells were counted using a
haemocytometer and the number of dead cells expressed as
a percentage of the total for each condition.
Fluorescence microscopic assays of cell viability
For the assessment of viable, necrotic and apoptotic cells,
BRIN-BD11 cells previously treated with fatty acids were
incubatedfor5 minwithamixtureof50 mg/mlHoechst33342
(Sigma) and 5 mg/ml propidium iodide (Sigma) dissolved in
PBS. Hoechst 33342 penetrates the plasma membrane of all
cells, staining the DNA blue. Viable cells appeared pale blue,
while apoptotic cells showed strong dark blue ﬂuorescence due
toDNAcondensation.Propidiumiodidecanpenetratethecells
only when their plasma membrane is damaged, leading to
ﬂuorescentpinkstainingofthenucleus.Consequently,necrotic
cells were identiﬁed by their ﬂuorescent pink colour. The
stained cells were examined by ﬂuorescence microscopy
(Jankowska et al. 1997). The percentages of viable, necrotic
and apoptotic cells were calculated after counting at least 100
cells for each experimental condition.
5-Bromo-2-deoxyuridine (BrdU) cell proliferation assay
Incorporation of BrdU, as an indication of cell proliferation,
was measured with a commercial kit (Amersham). BRIN-
BD11 cells were initially treated with fatty acids and then
seeded into 96-well plates at a density of 5000 cells/well for
24 h. BrdU label was added to the culture medium during
either 4 or 20 h of incubation, after which the cells were ﬁxed
and BrdU incorporation was assessed according to the
manufacturer’s instructions.
Analysis of phospholipid fatty acid composition and TAG
formation
Gas chromatography was used for assessment of the fatty acid
proﬁle of b-cell phospholipids. BRIN-BD11 cells were seeded
into 25 cm
2ﬂasks at adensityof1!10
6cells/ﬂask and were then
exposed to fattyacids. The cells were trypsinised and centrifuged
(200g; 5 min). Lipids were extracted by using a mixture of
chloroform:methanol (2:1, v/v) containing butylated hydroxy-
toluene (50 mg/l) as an antioxidant (Folch et al. 1957).
Phospholipids were separated from other lipid classes by solid
phaseextractionusingmethodsdescribedelsewhere(Burdgeetal.
2000) and were then saponiﬁed and methylated in methanol
containing 2% (v/v) H2SO4 at 50 8Cf o r2h .F a t t ya c i dm e t h y l
esters(FAME)wererecoveredbyextractionwithhexane.FAME
separationandanalysiswerecarriedoutusingaHewlettParckard
6890 gas chromatograph (Agilent Technologies, Wokingham,
Berks, UK) with a BPX-70 capillary column (30 m length,
220 mm internal diameter, 0.25 mm ﬁlm thickness, SGE Europe
Limited, Milton Keynes, Bucks, UK). The gas chromatograph
oven was programmed to hold for 2 min at the starting
temperature of C115 8C then increased at C10 8C/min to
200 8C and hold there for 10 min and ﬁnally raised at C60 8C/
m i nt o2 4 58C and hold for 4 min at the temperature of 245 8C.
FAME were identiﬁed by comparison of peak retention times to
those of known standards. Chemstation software was used for
peakareaquantiﬁcation.Thequantityoffattyacidswascalculated
using appropriate internal standards.
Triglyceride (TG) levels of BRIN-BD11 cells were
measured with a commercial kit designed for analysis of
cellular triglyceride content (Zen-bio Triglyceride Assay Kit
# TG-1-NC). Cells were seeded into 24-well plates at
densities of 1!10
5cells/well and treated with the appropriate
test reagents for 18 h. They were then lysed and processed
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standard glycerol solutions provided in the kit. TG levels were
estimated from the release of glycerol in experimental samples
and were measured spectrophotometrically at 540 nm.
Insulin secretion
BRIN-BD11 cells were seeded into 24-well plates at a density
of 5!10
4 cells/well and incubated for 18 h in the absence or
presence of fatty acids, as appropriate. The medium was then
removed and the cells washed and incubated in a bicarbonate-
buffered physiological saline solution (Gey & Gey 1936)
containing 4 mM glucose and 1 mg/ml BSA for 1 h. This
buffer was then replaced with fresh incubation buffer
containing test reagents and insulin secretion measured by
RIA after incubation at 37 8C for 1 h.
Data analysis
All experiments were performed on at least three separate
occasions and triplicates of each condition were used in each
experiment. Theresults are expressed asmeanGS.E.M. and the
level of signiﬁcance was calculated by using Student’s t-test or
ANOVA and was regarded as signiﬁcant when P!0.05.
Results
Effects of fatty acids on b-cell viability
In conﬁrmation of previous observations (Welters et al. 2004,
2006), incubation of BRIN-BD11 cells with palmitate dose-
dependently reduced their viability as judged by either trypan
blue exclusion or staining with propidium iodide/Hoechst
33342. This effect was primarily due to increased apoptosis as
judged by ﬂuorescence microscopy after staining with
propidium iodide and Hoechst 33342 (Fig. 1). By contrast,
palmitoleate was not toxic to the cells at concentrations up to
0.25 mM. Cells exposed to both palmitate and palmitoleate
simultaneously also retained viability (0.25 mM palmitate
alone: 89G8% non-viable cells; 0.25 mM palmitoleate alone:
9G3% non-viable cells; palmitate plus palmitoleate: 19G3%
non-viable cells (P!0.001 versus palmitate alone)),
suggesting that palmitoleate was actively protective against
palmitate-induced cytotoxicity.
Examination of the cytoprotective effect of palmitoleate at the level
of b-cell growth
It was important to establish whether the protective actions of
palmitoleate result in true preservation of b-cell viability or
whether this fatty acid simply delays the onset of apoptosis
beyond the time course of the present experiments. Avariety
of methods were employed to determine this and, in
particular, studies were undertaken to examine b-cell growth
and proliferation following exposure to different fatty acids.
Initially, BRIN-BD11 cells were treated with 0.25 mM
palmitate alone, 0.25 mM palmitoleate alone or a com-
bination of the two fatty acids for 18 h, after which time the
fatty acids were removed and the culture medium replaced.
Cell growth was then monitored over the ensuing period
(Fig. 2). The results revealed that 18-h exposure to palmitate
led to a marked loss of viability (up to 80%) and, as expected,
these cells failed to proliferate during subsequent incubation.
By contrast, those cells that had been treated with
palmitoleate alone or with palmitoleate in the presence of
palmitate exhibited an increased rate of proliferation over the
period following initial fatty acid treatment. Thus, the
protection afforded by palmitoleate extended not only to
maintaining cell viability but also to facilitating cell
Figure1 Modeofb-celldeathfollowingexposuretopalmitate.BRIN-
BD11 cells were treated for 18 h in the absence (control) or presence
of0.1 mMpalmitate.Thenumbersoflive(whitebars),apoptotic(solid
grey bars) and necrotic (cross-hatched bars) cells were estimated by
ﬂuorescence microscopy after staining with propidium iodide and
Hoechst 33342. *Signiﬁcantly reduced (P!0.001) when compared
with vehicle-treated cells; **signiﬁcantly increased (P!0.001) when
compared with vehicle-treated cells.
Figure 2 Effects of fatty acids on b-cell proliferation. BRIN-BD11
cells were initially incubated either in the absence of fatty acids
(squares) or in the presence of 0.25 mM palmitate alone (triangles),
0.25 mM palmitoleate alone (circles) or the combination of
0.25 mM palmitate plus 0.25 mM palmitoleate (inverted triangles)
for 18 h. After this time, the fatty acids were removed, the culture
medium replaced and cell growth monitored over the subsequent
72 h. *P!0.05 when compared with untreated cells; **P!0.01
when compared with untreated cells.
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exposed to either palmitoleate alone or palmitoleate plus
palmitate was signiﬁcantly higher than that measured in cells
treated with vehicle alone (Fig. 2).
Further conﬁrmation that palmitoleate treatment results in
enhanced cell growth was achieved by measuring b-cell DNA
synthesis more directly following fatty acid exposure (Fig. 3).
To achieve this, BRIN-BD11 cells were exposed to BrdU
following the relevant culture period with fatty acids. Cells
treated with palmitate alone showed reduced proliferation
when compared with control (as evidenced by attenuated
incorporation of BrdU), whereas those treated with
palmitoleate (either alone or in the combined presence of
palmitate) demonstrated the highest levels of DNA synthesis
(Fig. 3). Indeed, the rate of DNA synthesis measured under
these conditions surpassed that of cells grown in complete
medium throughout (complete medium: 0.18G0.01 A450
units; palmitoleate: 0.22G0.01 units; P!0.01).
The cytoprotection afforded by palmitoleate over an 18-h
incubation period also extended to the preservation of the
insulin secretory function of the cells (Fig. 4). Insulin
secretion from cells exposed to palmitate alone could not be
tested due to the extensive loss of viability under these
conditions. However, cells exposed to palmitate in the
presence of palmitoleate (where viability was maintained)
responded to a nutrient stimulus, a-ketoisocaproate, with an
equivalent response to that seen in untreated controls (Fig. 4)
or those exposed to palmitoleate alone. Thus, at least during
18 h of fatty acid exposure, insulin secretion was not
compromised when the monounsaturate was present.
Measurement of the lipid content of b-cells cultured in the presence
of fatty acids
It has been proposed that the behaviour of b-cells following
fatty acid exposure is determined by alterations in lipid
disposition, but this area remains controversial since both
protectiveanddetrimentalaffectshavebeenattributedtoaltered
lipidhandling.Therefore,toevaluatetheeffectsof fattyacidson
lipid formation in cultured b-cells, lipids were extracted from
BRIN-BD11 cells and their fattyacid composition analysed by
gas chromatography. Initial experiments were undertaken to
establish the total fatty acid composition of the neutral and
phospholipid fractions within BRIN-BD11 cells incubated
under control conditions. The results demonstrated that the
most abundant fatty acid species were palmitate (C16:0), oleate
(C18:1n-9), stearate (C18:0) and linoleate (C18:2n-6) with
lower, but measurable amounts of palmitoleate (C16:1n-7) and
arachidonate (C20:4n-6; Fig. 5).
Figure 3 Measurement of DNA synthesis in cells exposed to fatty
acids. BRIN-BD11 cells were cultured with vehicle (white bars)
0.25 mM palmitate (solid grey bars), 0.25 mM palmitoleate
(hatched bars) or 0.25 mM palmitate plus 0.25 mM palmitoleate
(cross-hatched bars) for 18 h. The level of cell proliferation was
estimated via the incorporation of BrdU during the incubation
period. *P!0.01 when compared with untreated cells.
Figure 4 Insulin secretory responses of BRIN-BD11 cells following
exposure to fatty acids. Cells were cultured for 18 h either without
fatty acids (UT) or in the presence of 0.25 mM palmitoleate alone
(PO) or 0.25 mM palmitoleate plus 0.25 mM palmitate (PCPO).
They were then washed and incubated in buffer containing 4 mM
glucose alone (control; white bars) or 4 mM glucose plus 10 mM
a-ketoisocaproate (KIC; grey bars) for 1 h. After this time, the
medium was sampled and insulin was measured by RIA. *P!0.01
relative to the absence of KIC.
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an alteration in their phospholipid fatty acid proﬁle, without
any change in the total phospholipid content. The total
content of fatty acids present in phospholipids was
w120 mg/10
6 cells, suggesting that this pool of fatty acid
(FA) is large with respect to the total that is esteriﬁed within
TAG (see below). As expected, the alterations in the
phospholipids FA proﬁle mirrored the relative availability of
eachfattyacidintheculturemedium(Fig.6).Thus,palmitate-
treated cells displayed an elevation of palmitate in the
phospholipidfraction,consistentwithincreasedincorporation
of this fatty acid under these conditions. This occurred
primarily at the expense of oleate and stearate. By contrast,
palmitoleate-treated cells displayed an elevation of this fatty
acid in their phospholipids with a concomitant reduction in
palmitate, stearate and oleate. Cells exposed to both palmitate
and palmitoleate showed an intermediate increase in the
incorporation of each of these species within their
phospholipids.
In addition to altering the phospholipid fatty acid
composition of BRIN-BD11 cells, exposure to elevated
concentrations of exogenous fatty acids also affected their
TAG content (Fig. 7a). The total amount of FA contained
within the TAG fraction amounted to w25 mg/10
6 cells and,
as such, this represents a smaller pool than that held in
phospholipids. Nevertheless, addition of either 0.25 mM
palmitate or 0.25 mM palmitoleate to the culture medium
signiﬁcantly raised the total TAG content of BRIN-BD11
cells by comparison with control cells. Culture of cells in the
simultaneous presence of palmitate and palmitoleate for 18 h
resulted in a further rise in TAG, such that the net effect was
additive (Fig. 7a).
To investigate these effects further and to discover whether
altered TAG levels show any correlation with the changes in
viability observed in response to different fatty acids, the
effects of a range of additional conditions were also examined.
Initially, 2-bromopalmitate (2-BP), an analogue of palmitate
that can be thioesteriﬁed to Coenzyme-A but cannot then be
further metabolised, was studied. The 2-BP is expected to
reduce the total Coenzyme-A pool by sequestration (Chase &
Tubbs 1972, Oakes et al. 1999) and thereby to cause a
reduction in TAG synthesis from exogenous palmitate. In
support of this, TAG formation was inhibited in cells exposed
to palmitate plus 2-BP when compared with cells exposed to
palmitate alone (Fig. 7a). This result conﬁrms that b-cell TAG
formation is inﬂuenced by the availability of FFA for
esteriﬁcation.
Next, methyl-palmitoleate, an analogue of palmitoleate
that cannot be esteriﬁed to Co-enzyme A, was employed. As
expected, exposure of cells to methyl-palmitoleate alone,
failed to inﬂuence their TAG content (Fig. 7a). More
signiﬁcantly, the co-presence of this fatty acid failed to alter
the TAG content of palmitate-treated cells, suggesting that it
did not alter the metabolic routing of palmitate into TAG
(Fig. 7a). To conﬁrm this result, additional studies were
conducted in which the fatty acid composition of BRIN-
BD11 cell TAG was analysed after incubation of cells with
palmitate and methyl-palmitoleate. As predicted, the
increased incorporation of palmitate into TAG seen under
these conditions was not attenuated by the presence of
methyl-palmitoleate (control cells: 1.77G0.04 mg palmitate
in TAG/10
6 cells; 0.25 mM palmitate alone: 2.57G0.28 mg
(P!0.01); 0.25 mM methyl-palmitoleate alone: 1.02G
0.14 mg; palmitate plus methyl-palmitoleate: 2.39G0.11 mg
(not signiﬁcantly different from palmitate alone)). Despite
this, methyl-palmitoleate abolished the cytotoxicity induced
by palmitate as revealed by cell viability assays (Fig. 7b).
Indeed, its protective actions were equipotent with palmi-
toleate (Fig. 8) and, like palmitoleate, it also promoted b-cell
growth following co-incubation with palmitate (not pre-
sented). Thus, the cytoprotective and growth-promoting
properties of methyl-palmitoleate and palmitoleate were
Figure 5 Fatty acid species present in untreated BRIN-BD11 cells.
BRIN-BD11 cells were grown in complete medium and their total
fatty acid composition analysed by gas chromatography after lipid
extraction.
Figure 6 Fattyacid composition of the phosphatidylcholine fraction
of BRIN-BD11 cells following incubation with exogenous fatty
acids. BRIN-BD11 cells were treated with vehicle (C) 0.25 mM
palmitate (P) 0.25 mM palmitoleate (PO) or 0.25 mM palmitate
plus 0.25 mM palmitoleate (PCPO) for 18 h. Phosphatidylcholine
(PC) was extracted as a representative phospholipid and quantiﬁed
by gas chromatography. Results are presented as the percentage of
each fatty acid measured within the PC fraction under the relevant
experimental conditions.
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effects on the TAG content of palmitate-treated cells.
Etomoxir, an inhibitor of carnityl palmitoyltransferase-1
(CPT-1), attenuates the uptake of fatty acids into mito-
chondria thereby reducing the rate of b-oxidation (Chen et al.
1994) and promoting fatty acid availability for TAG synthesis.
Accordingly, treatment of BRIN-BD11 cells with etomoxir
in the presence of palmitate resulted in enhanced TAG
formation by comparison with cells exposed to palmitate
alone (Fig. 7a). However, viability assays revealed that the
extent of cell death under these conditions was lower than
that seen with palmitate alone (Fig. 7b).
Discussion
It has become increasingly clear that long-chain fatty acids
exert complex, time-dependent effects on pancreatic b-cells,
with short-term exposure leading to enhancement of insulin
secretion, while chronic treatment is associated with
attenuated insulin secretion and reduced viability (Zhou &
Grill 1994, Milburn et al. 1995, Unger 1995, Bollheimer et al.
1998, Shimabukuro et al. 1998b, McGarry & Dobbins 1999).
The latter has sometimes been called ‘lipotoxicity’ and could
be taken as a relatively non-speciﬁc process arising from a
generalised elevation in circulating fatty acid concentrations
in vivo. Lipotoxicity can also be observed in vitro (Shimabu-
kuro et al. 1998b, Cnop et al. 2001, Eitel et al. 2002, Lupi et al.
2002, Piro et al. 2002, Maestre et al. 2003, Welters et al. 2004,
Mofﬁtt et al. 2005, Azevedo-Martins et al. 2006) when
pancreatic b-cells are incubated in the presence of exogenous
fatty acids although it is clear that under these conditions, loss
of b-cell viability occurs over a much shorter timescale than
that seen in vivo. Indeed, since the combinations of fatty acids
Figure 8 Dose-dependent inhibition of palmitate-induced b-cell
death by palmitoleate and methyl-palmitoleate. BRIN-BD11 cells
were incubated with increasing concentrations of palmitoleate
(squares) or methyl-palmitoleate (circles) in the presence of
0.25 mM palmitate for 18 h. The extent of cell death was estimated
after staining with trypan blue. Signiﬁcant inhibition (P!0.05) of
palmitate-induced cytotoxicitywas achievedwithconcentrationsof
0.025 mM or greater for both palmitoleate and methyl-
palmitoleate.
Figure 7 Triglyceride (TG) content (a) and cell viability (b) offatty acid
treated b-cells. BRIN-BD11 cells were treated for 18 h with vehicle
(white bars) 0.25 mM palmitoleate (solid grey bars), 0.25 mM 2-
bromopalmitate (right-hatched bars) 0.25 mM methyl-palmitoleate
(left-hatched bars) or 200 mg/ml etomoxir (cross-hatched bars) in the
absence (control) or presence of 0.25 mM palmitate. The cells were
then either lysed for analysis of intracellular triglyceride (a) or stained
with trypan blue to assess their viability (b). (a)*P!0.01 when
compared with vehicle-treated cells. **P!0.01 when compared
withcellsexposedtopalmitatealone.***P!0.05whencomparedwith
cells exposed to palmitate alone. (b) *P!0.01 when compared
with cells exposed to palmitate alone.
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data must always be interpreted with caution. Nevertheless, it
is accepted that in vitro models of lipotoxicity can provide
important information about the underlying mechanisms
involved (Newsholme et al. 2007).
In the present work, we have used an in vitro system to
demonstrate that saturated and unsaturated fatty acids differ
markedly in their ability to regulate b-cell viability. In
particular, the results reveal that the long-chain saturated
fatty acid palmitate readily promotes b-cell apoptosis,
whereas the monounsaturated palmitoleate is potently
cytoprotective. Thus, at least under in vitro conditions, the
ability to induce b-cell lipotoxicity appears to be a feature
that is characteristic mainly of long-chain saturated fatty acids
(Eitel et al. 2002, El-Assaad et al. 2003, Maedler et al. 2003,
Welters et al. 2004, 2006).
One area of speciﬁc controversy concerns the role played
by intracellular TAG in mediating the cytotoxic actions of
long-chain fatty acids. Some workers have considered
intracellular TAG stores as potential mediators of lipotoxicity
(Shimabukuro et al. 1998a,b) by virtue of their capacity to
mediate the physical disruption of cells (Mofﬁtt et al. 2005).
Conversely, others have suggested that TAG represents a
reservoir of intracellular lipid into which exogenous FFA can
be sequestered as a means to minimise any cytotoxic potential
(Cnop et al. 2001, Listenberger et al. 2003). This issue remains
unresolved and, in the present studies, we have attempted to
clarify the situation by monitoring b-cell TAG formation in
parallel with alterations in viability when cells are exposed to
saturated and unsaturated fatty acids either alone or in
combination.
As expected, fatty acid treatment caused a net increase in
total TAG formation in BRIN-BD11 cells. The magnitude of
this increase was similar when cells were exposed to either
palmitate or palmitoleate alone (0.25 mM) and,when the two
fatty acids were combined, an additive increase in TAG
formation was seen. These results conﬁrm that the
intracellular TAG pool plays an active role in sequestration
of exogenous fatty acids during incubation of BRIN-BD11
b-cells in vitro (Dixon et al. 2004).
Mofﬁtt et al. (2005) have argued that the species of TAG
formed during fatty acid exposure of b-cells may be critical in
determining the ﬁnal outcome in terms of overall cell
viability. In particular, they suggest that TAG species that
contain predominantly palmitate may be particularly cyto-
toxic and that the apparent protective actions of mono-
unsaturates could be due to their ability to alter the TAG
composition. In order to address this issue, we employed a
derivative of palmitoleate which is methylated on the
carboxyl group and, as a consequence, cannot be incorpor-
ated into TAG. In support of this, incubation of BRIN-BD11
cells with 0.25 mM methyl-palmitoleate failed to generate an
increase in TAG and it did not modify the extent of TAG
formation seen in palmitate-treated cells. Moreover, this FA
failed to attenuate the increase in palmitate incorporation into
TAG when the two FAs were added in combination,
suggesting that under these conditions, the TAG was still
predominantly composed of tripalmitin.
Despite its failure to modify TAG levels in palmitate-
treated cells, methyl-palmitoleate completely recapitulated
the cytoprotective actions of its parent compound, palmi-
toleate, and it was equipotent with palmitoleate in this
respect. These results suggest very strongly that the ability of
the monounsaturates to promote b-cell viability in cells
exposed to palmitate does not occur as a direct consequence
of altered TAG formation or altered TAG composition. They
also imply that the TAG formed in palmitate-treated cells is
not directly cytotoxic since methyl-palmitoleate failed to
modify TAG but maintained cell viability.
Additional support for these conclusions comes from the
results of experiments performed with an inhibitor of CPT-1,
etomoxir. CPT-1 catalyses the transit of fatty acids from the
cytosol into the mitochondria where they are then available
for metabolism by b-oxidation. Inhibition of CPT-1 there-
fore increases the availability of fatty acids in the cytosol,
leading to theirdiversion away fromoxidativemetabolism and
towards TAG formation. Accordingly, cells exposed to
palmitate plus etomoxir contained more TAG than cells
exposed to either compound alone. Moreover, since this
increase in TAG occurred in response to the addition of
exogenous palmitate, it is reasonable to deduce that it was
relatively enriched in palmitate (i.e. that it was mainly
tripalmitin). Despite this, the overall extent of cell viability
was not further decreased under these conditions but, rather,
etomoxir attenuated the loss of viability caused by palmitate.
Taken together, the data obtained with palmitoleate,
methyl-palmitoleate and etomoxir reveal that changes in the
formation of TAG from exogenous palmitate do not correlate
with altered viability and they imply that TAG formation
from palmitate is not directly cytotoxic under these
conditions. Indeed, as proposed by Cnop et al. (2001), the
results are not inconsistent with the possibility that TAG
formation from palmitate can, under certain circumstances,
be directly cytoprotective to b-cells (although this is unlikely
to account completely for the protection afforded by
monounsaturated fatty acids reported here).
In addition to causing alterations in TAG formation,
exposure of b-cells to fatty acids also changed the relative
composition of the cellular phospholipid pool, and this
occurred in concert with the prevailing fatty acid availability.
These observations imply that aspects of cell function that are
determined largely by the physical properties of cellular
membranes could vary in response to different exogenous
fatty acids. Indeed, such effects may well contribute to the
differential toxicity of saturated versus unsaturated molecules,
perhaps by altering the activity of lipid-dependent enzymes
such as phospholipases.
The results obtained in the current study also provide a
number of additional insights into the actions of fatty acids in
b-cells. Most importantly, they reveal that the effects of
monounsaturates are not limited to the blockade of apoptosis
but they show that as reported for breast cancer cells (Hardy
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growth and proliferation of b-cells. The cytoprotection
achieved by palmitoleate during an 18-h incubation period
also preserved the insulin secretory responses of the cells.
The ﬁnding that the cytoprotective and mitogenic actions
of palmitoleate were preserved when the carboxyl group of
the fatty acid was methylated implies that these actions were
not secondary to increased metabolism of palmitoleate. The
present work has not disclosed the molecular mechanisms
involved, but it is noteworthy that some actions of fatty acids
in b-cells are nowattributed to the activation of a subgroup of
G-protein-coupled receptors (GPRs; Itoh et al. 2003,
Kotarsky et al. 2003, Fujiwara et al. 2005, Hardy et al. 2005,
Salehi et al. 2005, Steneberg et al. 2005, Gromada 2006,
Schnell et al. 2007). One such molecule, GPR120, has
recently been reported to mediate the anti-apoptotic effects of
fatty acids in intestinal L-cells (Katsuma et al. 2005), but it
remains to be determined whether GPR120 may be
responsible for mediating the actions of monounsaturates
observed in the present study.
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